OBJECTIVE: Common diseases often have an inflammatory component reflected by associated markers such as serum C-reactive protein (CRP) levels. Circulating CRP levels have also been associated with adipose tissue as well as with specific CRP genotypes. We examined the interaction between measures of body mass index (BMI), waist circumference and fat percent (total fat measured by bioimpedance) with genotypes of the CRP gene in the determination of CRP levels. METHODS: The first 2296 participants (mean age 76+/-6 years, 42% men) in the Age, Gene/Environment Susceptibility-Reykjavik Study, a multidisciplinary epidemiological study to determine risk factors in aging, were genotyped for 10 single nucleotide polymorphisms (SNPs) in the CRP gene. General linear models with age and terms for interaction of CRP genotypes with BMI, waist circumference and percent fat were used to evaluate the association of genotypes to CRP levels (high-sensitivity method, range 0-10 mg l(-1)) in men and women separately. RESULTS: We focused on the SNP rs1205 that represents the allele that captures the strongest effects of the gene on CRP levels. Carriers of the rs1205 G allele had significantly higher CRP levels than noncarriers in a dose-dependent manner. Compared to the AA genotype, the slope of the increase in CRP with increasing BMI (P=0.045) and waist circumference (P=0.014) was different for the G allele carriers and of similar magnitude in both men and women. The rs1205 interactions were not significant for fat mass percent, suggesting a possible association with fat localization. CONCLUSIONS: This study further illuminates the known association between measures of adiposity and CRP levels and is shown to be dependent on variation in the rs1205 SNP of the CRP gene. The correlated increase in CRP levels with adiposity is accentuated by presence of the G allele.
OBJECTIVE: Common diseases often have an inflammatory component reflected by associated markers such as serum C-reactive protein (CRP) levels. Circulating CRP levels have also been associated with adipose tissue as well as with specific CRP genotypes. We examined the interaction between measures of body mass index (BMI), waist circumference and fat percent (total fat measured by bioimpedance) with genotypes of the CRP gene in the determination of CRP levels. METHODS: The first 2296 participants (mean age 76+/-6 years, 42% men) in the Age, Gene/Environment Susceptibility-Reykjavik Study, a multidisciplinary epidemiological study to determine risk factors in aging, were genotyped for 10 single nucleotide polymorphisms (SNPs) in the CRP gene. General linear models with age and terms for interaction of CRP genotypes with BMI, waist circumference and percent fat were used to evaluate the association of genotypes to CRP levels (high-sensitivity method, range 0-10 mg l(-1)) in men and women separately. RESULTS: We focused on the SNP rs1205 that represents the allele that captures the strongest effects of the gene on CRP levels. Carriers of the rs1205 G allele had significantly higher CRP levels than noncarriers in a dose-dependent manner. Compared to the AA genotype, the slope of the increase in CRP with increasing BMI (P=0.045) and waist circumference (P=0.014) was different for the G allele carriers and of similar magnitude in both men and women. The rs1205 interactions were not significant for fat mass percent, suggesting a possible association with fat localization. CONCLUSIONS: This study further illuminates the known association between measures of adiposity and CRP levels and is shown to be dependent on variation in the rs1205 SNP of the CRP gene. The correlated increase in CRP levels with adiposity is accentuated by presence of the G allele.
Authors: Christopher S Carlson; Shelley Force Aldred; Philip K Lee; Russell P Tracy; Stephen M Schwartz; Mark Rieder; Kiang Liu; O Dale Williams; Carlos Iribarren; E Cora Lewis; Myriam Fornage; Eric Boerwinkle; Myron Gross; Cashell Jaquish; Deborah A Nickerson; Richard M Myers; David S Siscovick; Alexander P Reiner Journal: Am J Hum Genet Date: 2005-05-16 Impact factor: 11.025
Authors: Dilys J Freeman; John Norrie; Muriel J Caslake; Allan Gaw; Ian Ford; Gordon D O Lowe; Denis St J O'Reilly; Chris J Packard; Naveed Sattar Journal: Diabetes Date: 2002-05 Impact factor: 9.461
Authors: John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason Journal: N Engl J Med Date: 2004-04-01 Impact factor: 91.245
Authors: Ghenadie Curocichin; Ying Wu; Thomas W McDade; Christopher W Kuzawa; Judith B Borja; Li Qin; Ethan M Lange; Linda S Adair; Leslie A Lange; Karen L Mohlke Journal: J Hum Genet Date: 2011-09-22 Impact factor: 3.172
Authors: Sarah C Markt; Jennifer R Rider; Kathryn L Penney; Fredrick R Schumacher; Mara M Epstein; Katja Fall; Howard D Sesso; Meir J Stampfer; Lorelei A Mucci Journal: Prostate Date: 2014-05-20 Impact factor: 4.104
Authors: Sarinnapha Vasunilashorn; Caleb E Finch; Eileen M Crimmins; Suvi A Vikman; Jonathan Stieglitz; Michael Gurven; Hillard Kaplan; Hooman Allayee Journal: Biodemography Soc Biol Date: 2011
Authors: Martha L Slattery; Karen Curtin; Elizabeth M Poole; David J Duggan; Wade S Samowitz; Ulrike Peters; Bette J Caan; John D Potter; Cornelia M Ulrich Journal: Int J Cancer Date: 2010-11-28 Impact factor: 7.396
Authors: Abbas Dehghan; Josée Dupuis; Maja Barbalic; Joshua C Bis; Gudny Eiriksdottir; Chen Lu; Niina Pellikka; Henri Wallaschofski; Johannes Kettunen; Peter Henneman; Jens Baumert; David P Strachan; Christian Fuchsberger; Veronique Vitart; James F Wilson; Guillaume Paré; Silvia Naitza; Megan E Rudock; Ida Surakka; Eco J C de Geus; Behrooz Z Alizadeh; Jack Guralnik; Alan Shuldiner; Toshiko Tanaka; Robert Y L Zee; Renate B Schnabel; Vijay Nambi; Maryam Kavousi; Samuli Ripatti; Matthias Nauck; Nicholas L Smith; Albert V Smith; Jouko Sundvall; Paul Scheet; Yongmei Liu; Aimo Ruokonen; Lynda M Rose; Martin G Larson; Ron C Hoogeveen; Nelson B Freimer; Alexander Teumer; Russell P Tracy; Lenore J Launer; Julie E Buring; Jennifer F Yamamoto; Aaron R Folsom; Eric J G Sijbrands; James Pankow; Paul Elliott; John F Keaney; Wei Sun; Antti-Pekka Sarin; João D Fontes; Sunita Badola; Brad C Astor; Albert Hofman; Anneli Pouta; Karl Werdan; Karin H Greiser; Oliver Kuss; Henriette E Meyer zu Schwabedissen; Joachim Thiery; Yalda Jamshidi; Ilja M Nolte; Nicole Soranzo; Timothy D Spector; Henry Völzke; Alexander N Parker; Thor Aspelund; David Bates; Lauren Young; Kim Tsui; David S Siscovick; Xiuqing Guo; Jerome I Rotter; Manuela Uda; David Schlessinger; Igor Rudan; Andrew A Hicks; Brenda W Penninx; Barbara Thorand; Christian Gieger; Joe Coresh; Gonneke Willemsen; Tamara B Harris; Andre G Uitterlinden; Marjo-Riitta Järvelin; Kenneth Rice; Dörte Radke; Veikko Salomaa; Ko Willems van Dijk; Eric Boerwinkle; Ramachandran S Vasan; Luigi Ferrucci; Quince D Gibson; Stefania Bandinelli; Harold Snieder; Dorret I Boomsma; Xiangjun Xiao; Harry Campbell; Caroline Hayward; Peter P Pramstaller; Cornelia M van Duijn; Leena Peltonen; Bruce M Psaty; Vilmundur Gudnason; Paul M Ridker; Georg Homuth; Wolfgang Koenig; Christie M Ballantyne; Jacqueline C M Witteman; Emelia J Benjamin; Markus Perola; Daniel I Chasman Journal: Circulation Date: 2011-02-07 Impact factor: 29.690
Authors: Nathaly Rius-Ottenheim; Anton J M de Craen; Johanna M Geleijnse; P Eline Slagboom; Daan Kromhout; Roos C van der Mast; Frans G Zitman; Rudi G Westendorp; Erik J Giltay Journal: Inflamm Res Date: 2011-10-07 Impact factor: 4.575
Authors: América Martínez-Calleja; Irma Quiróz-Vargas; Isela Parra-Rojas; José Francisco Muñoz-Valle; Marco A Leyva-Vázquez; Gloria Fernández-Tilapa; Amalia Vences-Velázquez; Miguel Cruz; Eduardo Salazar-Martínez; Eugenia Flores-Alfaro Journal: Exp Diabetes Res Date: 2012-09-25